Crop Life Science Limited

NSE: CLSL · Other · sector

₹76.60NSE close 2026-10-26

Key numbers

Market cap₹131 cr

Price₹76.60

52w high / low₹92 / ₹39

P/E20.2xSector median 14.4x

P/B1.6xSector median 1.7x

Book value₹49.1

Dividend yield–Sector median 0.37%

ROE8.0%Sector median 13.8%

ROCE10.6%Sector median 19.6%

OPM8.6%Sector median 10.4%

Debt / equity0.64xSector median 0.29x

EV/EBITDA10.2xSector median 8.4x

Interest cover2.7x

Current ratio1.55x

Sales growth 3y–Sector median +7.7%

Profit growth 3y–Sector median +16.6%

PEG–

Last 12 months to Mar 2026, Consolidated. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹3 cr vs borrowings ₹54 cr (FY26): borrowings are higher by ₹50 cr.
Operating profit covered interest 2.7x in the last 12 months.
Other income was 27% of net profit in the last 12 months.
No dividend in the last 2 financial years.
Price ₹76.60 on 2026-10-26: -17.0% from the 52-week high, +96.2% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹90.80 · low ₹41.05

Quarterly results

₹ cr	Mar 2025	Sep 2025	Mar 2026
Revenue	94	120	87
EBITDA	8	8	10
OPM %	8.5%	6.9%	11.0%
Other income	1	1	1
Net profit	3	3	4
EPS (₹)	1.54	2.31	1.48

Consolidated figures where filed. Latest quarter Mar 2026.

Profit & loss (yearly)

₹ cr	FY25	FY26	TTM
Revenue	201	207	207
EBITDA	16	18	18
Net profit	6	6	6
EPS (₹)	3.15	3.79	3.79
Revenue growth		+3.3%	–
Profit growth		+16.1%	–
Dividend / share (₹)	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	–	–	–
Net profit	–	–	–
EPS	–	–	–
Share price	–	+27.2% (2y)	+35.2%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	77	84
Borrowings	41	54
Cash & equivalents	1	3
Total assets	182	208
Fixed assets	32	25
Capital work in progress	0	0
Investments	1	1
Receivables	69	74
Inventory	49	71
Payables	42	52

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	-2	-8
Cash from investing	-4	2
Cash from financing	4	22
Capex	4	2
Free cash flow	-6	-10

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	7.2%	7.7%
ROCE %	10.6%	10.6%
Debtor days	126	131
Inventory days	126	170
Payable days	107	126
Cash conversion cycle (days)	145	175
Working capital days	90	111

Peers in Other

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
TSFINV	₹8,585 cr	17.6x	1.4x	8.4%	3.6%	20.5%	+121.7%	2.30%
KRISHANA	₹6,339 cr	39.9x	11.3x	41.6%	23.2%	12.6%	+95.7%	0.05%
MARINE	₹5,431 cr	84.2x	11.0x	14.3%	18.0%	10.8%	+25.6%	0.07%
ZOTA	₹4,139 cr	–	6.0x	-22.5%	-12.4%	-0.5%	+56.7%	0.07%
AIMTRON	₹3,319 cr	71.7x	17.1x	28.0%	31.8%	21.8%	–	–
ACCORD	₹2,984 cr	–	261.7x	12.4%	12.0%	2.4%	–	–
MONOLITH	₹2,646 cr	64.6x	24.3x	36.0%	48.7%	24.4%	–	–
UTSSAV	₹2,390 cr	40.2x	14.1x	43.4%	54.7%	7.9%	–	–
BETA	₹2,200 cr	40.6x	5.0x	16.4%	17.0%	20.8%	–	–
CLSL	₹131 cr	20.2x	1.6x	8.0%	10.6%	8.6%	–	–

All 688 companies in Other →

Documents

Links go to the original files on the exchange website.

About the company


Sector
Industry	Other
Sub-industry
Symbol	CLSL
BSE code	–
ISIN	INE00NH01017
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-26.